Related Experiment Video
Updated: Aug 17, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Recent advances in the treatment of systemic fungal infections
1Pediatric Branch, National Cancer Institute, Bethesda, Maryland.
Abstract:
Systemic fungal infections are life-threatening diseases that are occurring with increasing frequency, especially in immunocompromised patients. Advances in the treatment of systemic fungal infections have been achieved through better understanding of two classic antifungal drugs, amphotericin B and flucytosine, and through the recent development of several antifungal azole derivatives. The purpose of this paper is to review the recent advances in pharmacology, toxicology, formulation and clinical trials of antifungal agents for the treatment of systemic mycoses.
Related Concept Videos
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Antifungal Agents
Clinical Significance of Antibiotic Resistance

